Abstract-We compared the ability of separately measured intimal-medial thickness and atherosclerotic plaque to predict incident cardiovascular disease. American Indian men and women from the Strong Heart Study who were free of cardiovascular disease were evaluated with carotid ultrasound and cardiovascular disease risk factor assessment.
D
uplex carotid ultrasonography traditionally has been used as a clinical tool to evaluate the presence of significant stenosis in the setting of asymptomatic carotid bruit or clinical cerebrovascular disease. More recently, the technique has been utilized in epidemiological studies to detect subclinical vascular disease (intimal-medial thickness [IMT] and nonobstructive plaque) and to assess its relation to cardiovascular disease (CVD) risk factors and prevalent and incident cardiovascular disease. 1 Studies examining the prognostic value of carotid ultrasonography have varied in methodology. Importantly, IMT and plaque have not always been separately evaluated. Focal plaque is a direct manifestation of atherosclerosis, whereas IMT has been considered a measure of diffuse or early atherosclerosis. However, IMT is increased by hypertension because of medial hypertrophy unrelated to atherosclerosis 2 and is not increased in chronic inflammatory diseases despite markedly premature subclinical (and clinical) atherosclerosis manifest by focal plaque. [3] [4] [5] Thus protocols reporting wall thicknesses that incorporate focal plaque thickness conflate the 2 entities and thereby potentially overstate the prognostic importance of IMT.
Although a number of studies have separately examined IMT and plaque in relation to CVD outcomes, several limitations are noteworthy. Multivariable analyses including standard CVD risk factors have not always been performed to examine the independent or additive associations of carotid ultrasound findings. 6 -8 Some studies have limited CVD events to either myocardial infarction 6, 9, 10 or stroke. 11, 12 Other studies have examined combined carotid and femoral artery IMT 7, 8 or have used study-specific internal reference values of multiple averaged IMT segments. 13 Thus, the present study was designed to evaluate the separate prognostic associations of definite carotid atherosclerosis (presence and extent of plaque) and common carotid artery (CCA) wall thickness (IMT) and cross-sectional area in a population with high prevalence of hypertension and diabetes.
Subjects and Methods

Study Population
The Strong Heart Study is a population-based longitudinal study of prevalent and incident CVD and its risk factors in American Indians that began in 1989. Details of the study design have been previously published. 14, 15 At the third examination in 1997 to 1999, carotid ultrasonography was added to the study protocol.
Blood was drawn after a 12-hour fast to determine lipids, plasma glucose, and creatinine. Diabetes was defined by the American Diabetes Association criteria 16 as fasting plasma glucose Ն7.0 mmol/L (126 mg/dL) or by use of hypoglycemic treatment. Blood pressures were obtained in the seated position from the right brachial artery after 5 minutes of rest by trained personnel using an Omron 907 device (OMRON Healthcare, Kyoto, Japan). The mean of the second and third of three consecutive readings was recorded. Hypertension was defined by Joint National Committee 7 criteria 17 as systolic pressure Ն140 mm Hg, diastolic pressure Ն90 mm Hg, or current use of antihypertensive medication. Renal function was estimated using the Chronic Kidney Disease Epidemiology Collaboration equation. 18 Participants free of clinically overt CVD, including atrial fibrillation, at the third Strong Heart Study examination were included in analyses. The occurrence of fatal and nonfatal CVD events (myocardial infarction, coronary heart disease, sudden death, congestive heart failure, and ischemic stroke) was tabulated during follow-up, as previously described. 19, 20 Events were reviewed based on a range of International Classification of Diseases version 9 codes (390 -448, 250, 518.4, 585, 798); medical charts, autopsy reports, death certificates, and informant interviews about causes of death were independently reviewed by physician members of the Strong Heart Study morbidity and mortality committees using standard criteria. The study was approved by the participating tribes and Institutional Review Boards of the Indian Health Service and the participating institutions. Informed consent was obtained from all participants.
Carotid Ultrasonography
The extracranial carotid arteries were examined using a standardized protocol. 2, 21 Imaging was performed by field sonographers after central training using Acuson 128 systems equipped with a 7.5-MHz imaging transducer. With the subject in the supine position with slight hyperextension of the neck, the CCA, carotid bulb, and extracranial internal and external carotid arteries were identified. Two-dimensionally guided M-mode tracings of the distal CCA Ϸ1 cm proximal to the carotid bulb were obtained with simultaneous electrocardiogram and recorded on super VHS videotape. Videotapes were sent to the Reading Center at Weill Cornell Medical Center to be reviewed by an experienced cardiologist (M.J.R.). Suitable frames for measurement were obtained in real-time by use of a frame grabber (Imaging Technology, Woburn, MA) interfaced with a high-resolution (640ϫ640-pixel) video monitor and stored on diskettes.
All carotid measurements were performed on stored images by use of a mouse-driven computer program (ARTSS; Cornell University, New York, NY). The simultaneous electrocardiogram was used to time carotid artery measurements at end diastole. Carotid measurements included IMT of the far wall and end-diastolic diameter. All measurements were performed on several cycles and averaged. Carotid cross-sectional area, a measure of vascular volume or mass, was calculated as previously described. 21 Wall thickness and diameter measurements of the left and right common carotid arteries were averaged; averaged values were used in all analyses. Plaques are uncommon in the CCA, 22, 23 and wall thickness and diameter measurements were never obtained at the level of a discrete plaque. Carotid arteries were also scanned for evidence of atherosclerosis, defined as the presence of wall thickening at least 50% greater than that of the surrounding wall. 24 Plaque score, a semiquantitative measure of the extent of atherosclerosis, 11, 25, 26 was calculated by the number of left and right segments (common carotid, bulb, internal carotid, external carotid) containing plaque; thus, plaque score ranged from 0 to 8.
Statistical Analyses
Data are presented as meansϮSD or percents. For continuous variables, trends across categories defined by hypertension and diabetes status were assessed with analysis of variance using linear contrasts, with post hoc testing for multiple comparisons. Categorical variables were evaluated using 2 analysis. Relations of carotid ultrasound findings to cardiovascular events were determined in Cox regression analyses adjusting for age, sex, body mass index, waist circumference, current smoking, nonhigh-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, and estimated glomerular filtration rate. The nonhypertensive groups are additionally adjusted for systolic blood pressure and the nondiabetic groups are additionally adjusted for fasting glucose. Two-tailed PϽ0.05 was considered significant.
We tested for multiplicative interactions between vascular measures and sex, diabetes, and hypertension by including appropriate cross-product terms in Cox models. There was no significant effect-measure modification by sex for any of the 4 vascular measures (IMT, arterial mass, plaque, and plaque score) in relation to outcomes, but there was evidence of multiplicative interaction of diabetes status with both IMT (Pϭ0.021) and vascular mass (Pϭ0.001), and of hypertension status with both IMT (Pϭ0.001) and vascular mass (Pϭ0.001). Although similar effect-modification by diabetes or hypertension status was not observed for the presence (Pϭ0.424 and Pϭ0.714, respectively) or extent of atherosclerosis (Pϭ0.554 and Pϭ0.425, respectively), all analyses were stratified by diabetes status and by hypertension status. The C-statistic, which is equivalent to the area under the receiver-operating characteristic curve, was calculated as a measure of model discrimination. All analyses were performed with SPSS version 19 (SPSS, Chicago, IL) or STATA version 11 (Stata, College Station, TX).
Results
Population Characteristics and CVD Outcomes
A total of 2441 participants were free of prevalent clinical CVD at the time of examination. Mean age was 63Ϯ8 years (range, 51-84 years); 65% were women and body mass index was 31.3Ϯ6.6 kg/m 2 . Hypertension was present in 52.2% of the population, of whom 69% were using antihypertensive medications. Use of lipid-lowering therapy was uncommon at the time of examination (2.4%). Diabetes was present in 47.6% of the population, and 27.4% were active smokers. Among the 2441 participants, 495 (20.3%) experienced initial fatal and nonfatal CVD events (101 myocardial infarction, 204 definite coronary heart disease, 92 stroke, 98 congestive heart failure) during a mean follow-up of 7.7Ϯ2.8 years; 21.4% of initial events were fatal.
Traditional CVD risk factors, vascular biomarkers, and CVD outcomes are compared in Tables 1 and 2 stratified according to diabetes and hypertension status. Ages were higher and renal function was lower in the 2 groups with hypertension compared to the other 2 groups. Body mass index and waist circumference were higher and rates of smoking were lower in the groups with hypertension and/or diabetes compared to the normal group. Body mass index and waist circumference were also significantly higher in the 2 groups with diabetes compared to the group with hypertension alone. The proportion of men was lowest in those with both hypertension and diabetes. The 4 groups were compa-rable in levels of nonhigh-density lipoprotein cholesterol; however, the 2 groups with diabetes had significantly lower high-density lipoprotein cholesterol levels and significantly higher triglyceride levels than the normal group and the group with hypertension alone. As expected, systolic blood pressure was significantly higher in the hypertensive groups and fasting glucose was significantly higher in the diabetic groups.
Values of IMT, arterial mass, plaque prevalence, and plaque score were comparable in the groups with hypertension and/or diabetes and significantly higher compared to the normal group (Table 2) . Incident CVD was substantially higher in the groups with hypertension and/or diabetes compared to the normal group and substantially higher in the 2 groups with diabetes compared to the group with hypertension alone.
Relation of Vascular Biomarkers to Cardiovascular Disease Events
Results from the Cox models are presented in Table 3 . All 4 vascular imaging biomarkers were strongly associated with incident CVD in both age-adjusted and sex-adjusted and broadly adjusted models in the group with neither hypertension nor diabetes. However, neither IMT nor arterial mass was associated with outcomes in either model in the groups with hypertension and/or diabetes. In contrast, atherosclerotic plaque and plaque score were associated with outcomes in all 4 groups. In secondary analyses, adding use of antihypertensive or glucose-lowering medications to multivariable analyses did not substantially alter results (data not shown).
In the entire population, the C-statistic for prediction of events by risk factors alone (0.700; 95% CI, 0.674 -0.726) was significantly increased by addition of either plaque (C-statisticϭ0.714; 95% CI, 0.688 -0.739; Pϭ0.011) or plaque score (C-statisticϭ0.719; 95% CI, 0.694 -0.744; Pϭ0.001) to the model. In view of the significant effect modification observed for carotid IMT by hypertension and diabetes status, wherein carotid IMT was only predictive of outcome in the normal group, receiver-operator characteristic curve analyses using IMT were restricted to this group. Although addition of IMT substantially increased the magnitude of the C-statistic compared to the risk factor model alone (from 0.735 [95% CI, 0.678 -0.791] to 0.748 [95% CI, 0.690 -0.806), the change was not statistically significant (Pϭ0.198).
To determine whether carotid IMT might be more predictive of incident stroke or coronary artery disease than plaque, we performed additional analyses in the entire group because of the relatively small number of separate events in the 4 subgroups. Multivariable analyses adjusting for the covariates listed in Table 3 as well as for the presence or absence of diabetes and hypertension indicated that IMT was not an independent predictor of either coronary heart disease or of stroke, whereas atherosclerotic plaque was a strong independent predictor of coronary heart disease (heart rate, 1.88; 95% CI, 1.35-2.61; PϽ0.001) and plaque score was an independent predictor of stroke (heart rate, 1.19; 95% CI, 1.04 -1.35; Pϭ0.012).
Discussion
Our study shows that the presence and extent of carotid plaque, direct manifestations of atherosclerosis, are strong predictors of incident CVD, independent of the effects of diabetes, hypertension, and other established risk factors. Importantly, our findings are adjusted for both traditional CVD risk factors as well as estimated glomerular filtration rate, itself a potent predictor of CVD risk. In contrast, CCA IMT and arterial mass (cross-sectional area) were only predictive of CVD outcome in Strong Heart Study participants without diabetes and, particularly, hypertension. Our findings suggest that, in the absence of hypertension, these 2 vascular biomarkers may represent arterial wall thickening associated with atherosclerosis. In contrast, hypertensionassociated medial hypertrophy 2,21 is not independently related to CVD outcomes. Studies that have analyzed IMT and plaque separately generally show the greatest risk of future CVD events to be conferred by the presence of focal plaque. In one of the first such studies, 7 2000 healthy subjects aged 30 to 70 years were followed-up for 6 years after baseline carotid and femoral ultrasound examination. Cardiovascular events occurred in 5.5% of those with increased IMT (diffuse thickening Ͼ1 mm) and in 18.4% of those with plaque (focal thickening of IMT Ͼ2 mm). Similarly, in 10 000 healthy individuals followed-up for 10 years in the Cafes-Caves Study, incident CVD occurred in 8.6% of those with increased IMT and in 39.3% of those with plaque. 8 However, neither of these studies adjusted for CVD risk factors. In the Kuopio Ischemic Heart Disease Risk Factor Study of 2,181 middle-aged Finnish men, the 4-year risk of acute myocardial infarction was increased 2.1-fold in those with increased IMT (Ͼ1.0 mm) and 3.4-fold in those with nonobstructive plaque in comparison to those with normal carotid ultrasound studies; 6 again, results were not adjusted for CVD risk factors.
Three recent analyses in population-based studies separately examined IMT and plaque in relation to outcomes and adjusted for CVD risk factors. Among 1249 participants aged 18 to 99 years in the San Daniele Study, a town in northeastern Italy, the relative risk of ischemic cerebrovascular events (ischemic stroke or transient ischemic attack) was 5.6 (95% CI, 3.2-10.1) for CCA IMT Ͼ1 mm and 10.4 (95% CI, 6.4 -17.1) for Ն1 plaque compared to those with normal IMT and no plaque at baseline examination Ϸ12 years earlier. 12 The analyses included those with prevalent CVD at baseline, and data were not available from the baseline evaluation to examine IMT as a continuous measure.
In the Atherosclerosis Risk in Communities Study, categories (Ͻ25 th percentile, 25 th to 75 th percentile, Ͼ75 th percentile) of averaged CCA, bifurcation, and internal carotid artery IMT and plaque were added to the Atherosclerosis Risk in Communities 10-year coronary risk score in 13 145 participants without prevalent CVD at baseline. 13 The area under the receiver-operating characteristic curve significantly improved when plaque, but not IMT, was added to traditional risk factors in women. Although both plaque and IMT increased the area under the receiver-operating characteristic curve in men, the increase was greater for IMT than plaque. CI indicates confidence interval; DM, diabetes mellitus; HR, hazard ratio; HTN, hypertension; IMT, intimal-medial thickness; SD, standard deviation. *Multivariable models are adjusted for age, sex, body mass index, waist circumference, current smoking, non-HDL cholesterol, HDL cholesterol, triglycerides, and estimated glomerular filtration rate. The nonhypertensive groups are additionally adjusted for systolic blood pressure and the nondiabetic groups are additionally adjusted for fasting glucose.
Because this study evaluated averaged IMT measured from areas that might include plaque in the IMT measurement, it is possible that the significance of IMT in relation to outcomes is overstated. The extent of atherosclerosis, ie, the presence of plaques in multiple segments, was not examined in relation to outcome.
In 2965 members of the Framingham Offspring Study cohort followed-up for 7.2 years, mean IMT of the CCA, maximum IMT of the internal carotid artery, and plaque within the internal carotid artery (defined as IMT Ͼ1.5 mm) were all associated with incident cardiovascular events. 27 Only the internal carotid artery IMT and plaque resulted in an increase in the C-statistic generated by consideration of the Framingham risk score. The present study confirms this observation for both the presence and the extent of atherosclerosis. Similarly to the Framingham Offspring Study, the C-statistic was not significantly improved by addition of common carotid IMT in our study. However, our group of normal participants (no hypertension or diabetes) is relatively small and lacks sufficient power for assessment of the incremental discriminatory value of this measure. Larger studies of healthy individuals will be necessary to determine whether the increased magnitude of the C-statistic achieved by carotid IMT suggested here in fact represents genuine improvement in risk prediction.
An indirect validation of the superiority of carotid plaque over carotid IMT is provided by the substantially stronger relation of carotid plaque area to significant underlying coronary artery disease as evidenced by computed tomography angiogram. 28 Similarly, right carotid artery plaque area were more strongly related to incident myocardial infarction 10 and ischemic stroke 29 than carotid IMT in the Tromsø Study. These results are of particular interest because IMT measurement could incorporate plaque thickness if plaque was present in the predefined area where IMT measurements were performed. Although plaque area derived from a 2-dimensional ultrasound study may not be a precise measure of atherosclerosis burden, these findings are similar to those using the semiquantitative plaque score in the present study. The Rotterdam Study found IMT and plaque (evaluated as none vs at least 3 plaques using a plaque score) to be equally predictive of myocardial infarction independent of traditional risk factors; 9 the authors comment on the ease of plaque assessment compared to the precision required for IMT measurement. Furthermore, in the Rotterdam Study, increasing plaque score (0 -6) increased the risk of stroke 11 and, in a separate population of elderly men, plaque score independently predicted all-cause and cardiovascular mortality. 30 There is emerging interest in the concept of "vascular" as opposed to biological age 31, 32 as well as the optimal "vascular biomarker" to use as an adjunct to traditional risk stratification techniques. 33 Although a recent review 34 and a metaanalysis of published data 35 indicated that carotid IMT is a predictor of cardiovascular events, the authors conceded that IMT measurements were not uniformly made in plaque-free area and that focal plaque may have been included in IMT measurement as a consequence of study protocol dictating site of measurement or requiring "maximum IMT." The present study indicates that of vascular structural parameters, the presence and extent of direct evidence of atherosclerosis are more strongly associated with future risk of clinical CVD than is IMT. Interestingly, although carotid artery atherosclerosis is a manifestation of cerebrovascular disease, the majority of events predicted are attributable to coronary heart disease, underscoring both the systemic nature of atherosclerosis as well as the greater frequency of cardiac compared to cerebral manifestations.
There are several potential limitations to our study. In the Strong Heart Study, IMT was only measured in the distal CCA. Data from the Cardiovascular Health Study 36 and the British Regional Heart Study 37 suggest a stronger association of CCA IMT with prevalent stroke, whereas bifurcation or internal carotid artery IMT were more strongly related to prevalent myocardial infarction. However, adjusted relative risks for prediction of incident events were only marginally different between the CCA and internal carotid artery IMT in the Cardiovascular Health Study. 38 A major advantage of CCA IMT is its higher measurement yield compared to other segments. In the Atherosclerosis Risk in Communities Study, IMT measurements were obtainable from the CCA in 91.4%, from the bifurcation in 77.3%, and from the internal carotid artery in 48.6% of participants. 39 A report on 1881 Rotterdam Study participants showed a similar trend in measurement yield: 96% in the CCA, 64% in the bifurcation, and 31% in the internal carotid artery. 40 Measurement yield of CCA IMT in the current study was comparable to that in these earlier studies (96%). The present findings derive from a cohort of American Indians at high cardiometabolic risk, such that generalizability to other populations cannot be assumed. However, stratification and adjustment showed that the presence and extent of atherosclerosis were associated with incident CVD independent of diabetes and hypertension and other risk factors. Furthermore, the same traditional risk factors for cardiovascular disease in the general U.S. population have been shown to be operative in the Strong Heart Study population. 20 Although one cannot necessarily extrapolate results from this generally obese and insulin-resistant population to nonobese noninsulin-resistant populations, our findings will be applicable to a greater proportion of the broader population if current trends in the increasing prevalence of obesity and diabetes continue unabated.
Perspectives
The present study shows that unequivocal evidence of atherosclerosis (plaque) and its extent (plaque score) are independently associated with first incident CVD events in individuals, regardless of diabetes and hypertension status. In contrast, IMT and arterial mass were only found to be associated with CVD outcome in the absence of diabetes and hypertension, likely attributable to hypertension-mediated vascular hypertrophy, lessening the likelihood that diffuse vessel wall thickening and lumen dilatation are manifestations of atherosclerosis. 41 These findings highlight the value of plaque as a vascular biomarker and support the utility of separate assessment of focal atherosclerosis and IMT in epidemiological studies, as well as risk assessment protocols. Whether these direct measures of atherosclerosis afford improved risk prediction in selected subgroups warrants further study in larger samples.
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